649 related articles for article (PubMed ID: 25586899)
1. HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels.
O'Bryan TA; Rini EA; Okulicz J; Messner O; Ganesan A; Lalani T; Bavaro MF; O'Connell RJ; Agan BK; Landrum ML
HIV Med; 2015 Mar; 16(3):161-7. PubMed ID: 25586899
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B Virus Vaccination in HIV: Immunogenicity and Persistence of Seroprotection up to 7 Years Following a Primary Immunization Course.
Nicolini LA; Magne F; Signori A; Di Biagio A; Sticchi L; Paganino C; Durando P; Viscoli C
AIDS Res Hum Retroviruses; 2018 Nov; 34(11):922-928. PubMed ID: 29926738
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals.
Landrum ML; Hullsiek KH; Ganesan A; Weintrob AC; Crum-Cianflone NF; Barthel RV; O'Connell RJ; Fieberg A; Chun HM; Marconi VC; Dolan MJ; Agan BK;
AIDS; 2010 Feb; 24(4):545-55. PubMed ID: 19487908
[TBL] [Abstract][Full Text] [Related]
4. Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults.
Potsch DV; Camacho LA; Tuboi S; Villar LM; Miguel JC; Ginuíno C; Silva EF; Mendonça RM; Moreira RB; Barroso PF
Vaccine; 2012 Sep; 30(41):5973-7. PubMed ID: 22828589
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy.
Lao-Araya M; Puthanakit T; Aurpibul L; Taecharoenkul S; Sirisanthana T; Sirisanthana V
Vaccine; 2011 May; 29(23):3977-81. PubMed ID: 21473954
[TBL] [Abstract][Full Text] [Related]
6. The recombinant hepatitis B surface antigen vaccine in persons with HIV: is seroconversion sufficient for long-term protection?
Powis JE; Raboud J; Ostrowski M; Loutfy MR; Kovacs C; Walmsley SL
J Infect Dis; 2012 May; 205(10):1534-8. PubMed ID: 22448009
[TBL] [Abstract][Full Text] [Related]
7. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B vaccine responsiveness and clinical outcomes in HIV controllers.
Okulicz JF; Mesner O; Ganesan A; O'Bryan TA; Deiss RG; Agan BK
PLoS One; 2014; 9(8):e105591. PubMed ID: 25144773
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy of hepatitis B vaccination in healthcare workers of Oil Company Hospital, Tehran, Iran (1989-2005).
Alavian SM; Mansouri S; Abouzari M; Assari S; Bonab MS; Miri SM
Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):131-4. PubMed ID: 18188034
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
Bailey CL; Smith V; Sands M
Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381
[TBL] [Abstract][Full Text] [Related]
11. Immune response to hepatitis B vaccination in HIV-positive adults with isolated antibodies to HBV core antigen.
Kaech C; Pache I; Bürgisser P; Elzi L; Darling KE; Cavassini M
J Infect; 2012 Aug; 65(2):157-64. PubMed ID: 22410383
[TBL] [Abstract][Full Text] [Related]
12. Association between hepatitis B vaccine antibody response and CD4 reconstitution after initiation of combination antiretroviral therapy in HIV-infected persons.
Allen K; Mesner O; Ganesan A; O'Bryan TA; Deiss RG; Agan BK; Okulicz JF
BMC Infect Dis; 2015 May; 15():203. PubMed ID: 25928043
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
[TBL] [Abstract][Full Text] [Related]
14. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
[TBL] [Abstract][Full Text] [Related]
15. Does increased hepatitis B vaccination dose lead to a better immune response in HIV-infected patients than standard dose vaccination: a meta-analysis?
Ni JD; Xiong YZ; Wang XJ; Xiu LC
Int J STD AIDS; 2013 Feb; 24(2):117-22. PubMed ID: 23467291
[TBL] [Abstract][Full Text] [Related]
16. Immune responses to hepatitis B immunization 10-18 years after primary vaccination: a population-based cohort study.
Katoonizadeh A; Sharafkhah M; Ostovaneh MR; Norouzi A; Khoshbakht N; Mohamadkhani A; Eslami L; Gharravi A; Shayanrad A; Khoshnia M; Esmaili S; George J; Poustchi H; Malekzadeh R
J Viral Hepat; 2016 Oct; 23(10):805-11. PubMed ID: 27126365
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus (HBV) reverse seroconversion (RS) can be prevented even in non-responders to hepatitis B vaccine after allogeneic stem cell transplantation: long-term analysis of intervention in RS with vaccine for patients with previous HBV infection.
Takahata M; Hashino S; Onozawa M; Shigematsu A; Sugita J; Fujimoto K; Endo T; Kondo T; Tanaka J; Imamura M; Teshima T
Transpl Infect Dis; 2014 Oct; 16(5):797-801. PubMed ID: 25154638
[TBL] [Abstract][Full Text] [Related]
18. Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load.
Rey D; Krantz V; Partisani M; Schmitt MP; Meyer P; Libbrecht E; Wendling MJ; Vetter D; Nicolle M; Kempf-Durepaire G; Lang JM
Vaccine; 2000 Jan; 18(13):1161-5. PubMed ID: 10649616
[TBL] [Abstract][Full Text] [Related]
19. HIV-HBV vaccine escape mutant infection with loss of HBV surface antibody and persistent HBV viremia on tenofovir/emtricitabine without antiviral resistance.
Schirmer P; Winters M; Holodniy M
J Clin Virol; 2011 Nov; 52(3):261-4. PubMed ID: 21840252
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus prevalence and vaccine response in HIV-infected children and adolescents on combination antiretroviral therapy in Kigali, Rwanda.
Mutwa PR; Boer KR; Rusine JB; Muganga N; Tuyishimire D; Reiss P; Lange JM; Geelen SP
Pediatr Infect Dis J; 2013 Mar; 32(3):246-51. PubMed ID: 22976050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
